Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
WBP1LP1, short for WW domain binding protein 1-like pseudogene 1, is a pseudogene found in the human genome[4]. Pseudogenes are DNA sequences similar to known genes but usually lack the ability to encode functional proteins due to sequence disruptions or regulatory mutations. WBP1LP1 is related to the WW domain binding protein 1-like family, but it does not produce a functional protein product and has not been implicated in cellular signaling, disease, or therapeutic targeting. There is no evidence that this pseudogene serves as a receptor, enzyme, transporter, biomarker, or pharmacological target. Most of the research and functional insights are related to WBP1L (WW domain binding protein 1-like, a transmembrane adaptor protein with established roles in hematopoietic stem cells and leukemia prognosis)[1], but WBP1LP1 itself lacks documented biological or clinical relevance. If a therapeutic or biological context is intended, WBP1L (not a pseudogene) is likely the correct target[1]; WBP1LP1 appears to be non-functional and not suitable for structured molecular or pharmacological annotation.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on WW domain binding protein 1-like pseudogene 1 (WBP1LP1).